• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估临界点比率在普及抗逆转录病毒治疗时代监测艾滋病治疗项目的效用。

Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART.

作者信息

de Montigny Simon, Boily Marie-Claude, Mâsse Benoît R, Mitchell Kate M, Dimitrov Dobromir T

机构信息

CHU Sainte-Justine Research Center, Montreal, QC, Canada.

School of Public Health, University of Montreal, Montreal, QC, Canada.

出版信息

Infect Dis Model. 2018 Mar 14;3:85-96. doi: 10.1016/j.idm.2018.03.005. eCollection 2018.

DOI:10.1016/j.idm.2018.03.005
PMID:30839944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6326263/
Abstract

BACKGROUND

The epidemiological tipping point ratio (TPR) has been suggested as a useful indicator to monitor the scale-up of antiretroviral treatment (ART) programmes and determine when scale-up is sufficient to control the epidemic. TPR has been defined as the ratio of yearly number of new HIV infections to the yearly number of new ART initiations or to the yearly net increase in the number of people on ART. It has been used to rank the progress of treatment programmes across countries, with the objective of reaching a TPR value under 1. Our study aims to assess if TPR alone can be used as an indicator of ART success across settings by comparing the expected changes in HIV incidence and ART coverage when TPR is maintained constant over time. In particular, we focus on the effect of ART initiation timing (emphasis on ART being initiated early or late during HIV progression) on the interpretation of the TPR.

METHODS

We used a dynamic model of HIV transmission in South Africa representing ART rollout leading to universal treatment in 2017. The model is calibrated to HIV incidence, HIV prevalence and ART coverage in 2012 in South Africa, and 1000 simulations are selected for the base-case scenario. To measure the effect of TPR, we simulate TPR-preserving interventions, maintaining TPR (yearly number of new ART initiations denominator) at the value observed in 2019 (between 0.65 and 1.25) for 15 years. We compare ART coverage and HIV incidence across TPR values and across strategies in which ART access is prioritized differently. In a secondary analysis, we illustrate the sensitivity of new ART initiations to ART retention, and we compare both definitions of the TPR.

RESULTS

Our analysis shows that HIV incidence reduction is weakly correlated to TPR: the same reduction in HIV incidence (15%) can be achieved by implementing the same strategy with a wide range of TPR maintained (0.65-1.12). Assuming high retention in ART, TPR-preserving strategies prioritizing early ART initiation yield greater reduction in HIV incidence than strategies where most individuals initiate ART late. High ART coverage is associated with low HIV incidence and it can be reached with a TPR below or equal to one with strategies favoring early ART initiation. Low ART retention over time results in higher HIV incidence even if TPR is maintained low. If ART retention is low, strategies prioritizing late ART initiation are associated with lower HIV incidence than strategies where ART is initiated early. Maintaining a fixed TPR value based on the net increase in people on ART gives higher HIV incidence reduction and requires fast ART scale-up.

CONCLUSION

Our analysis suggests that the TPR is not an adequate indicator of ART programme impact, without information on ART coverage and retention. Achieving early initiation and adherence to treatment to improve ART coverage might be as important as attaining a specific TPR target. Comparisons of TPR in different settings should account for differences in epidemic conditions.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/a633b6b58f76/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/3e14d2963a0b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/531949b799d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/4d6e84f6de20/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/333ccbdd8f9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/2e3aa96c6221/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/a633b6b58f76/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/3e14d2963a0b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/531949b799d8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/4d6e84f6de20/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/333ccbdd8f9b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/2e3aa96c6221/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a874/6326263/a633b6b58f76/gr6.jpg
摘要

背景

流行病学临界点比率(TPR)被认为是监测抗逆转录病毒治疗(ART)项目扩大规模以及确定扩大规模何时足以控制疫情的有用指标。TPR被定义为每年新感染艾滋病毒的人数与每年开始接受抗逆转录病毒治疗的新人数或每年接受抗逆转录病毒治疗人数的净增加数之比。它已被用于对各国治疗项目的进展进行排名,目标是使TPR值低于1。我们的研究旨在通过比较当TPR随时间保持恒定时艾滋病毒发病率和抗逆转录病毒治疗覆盖率的预期变化,评估仅TPR是否可作为不同环境下抗逆转录病毒治疗成功的指标。特别是,我们关注抗逆转录病毒治疗启动时间(强调在艾滋病毒进展过程中抗逆转录病毒治疗是早启动还是晚启动)对TPR解释的影响。

方法

我们使用了一个南非艾滋病毒传播动态模型,该模型代表了抗逆转录病毒治疗的推广,到2017年实现普遍治疗。该模型根据2012年南非的艾滋病毒发病率、艾滋病毒流行率和抗逆转录病毒治疗覆盖率进行校准,并为基线情景选择1000次模拟。为了衡量TPR的影响,我们模拟保持TPR的干预措施,将TPR(每年开始接受抗逆转录病毒治疗的新人数分母)保持在2019年观察到的值(0.65至1.25之间)15年。我们比较不同TPR值以及抗逆转录病毒治疗获取优先级不同的策略下的抗逆转录病毒治疗覆盖率和艾滋病毒发病率。在二次分析中,我们说明了新开始接受抗逆转录病毒治疗对治疗保留率的敏感性,并比较了TPR的两种定义。

结果

我们的分析表明,艾滋病毒发病率的降低与TPR的相关性较弱:通过实施相同策略并保持广泛的TPR范围(0.65 - 1.12),可以实现相同的艾滋病毒发病率降低(15%)。假设抗逆转录病毒治疗保留率高,优先早期启动抗逆转录病毒治疗的保持TPR策略比大多数个体晚启动抗逆转录病毒治疗的策略能更大程度地降低艾滋病毒发病率。高抗逆转录病毒治疗覆盖率与低艾滋病毒发病率相关,通过优先早期启动抗逆转录病毒治疗的策略,TPR低于或等于1时即可实现高覆盖率。随着时间推移,抗逆转录病毒治疗保留率低会导致艾滋病毒发病率更高,即使TPR保持较低水平。如果抗逆转录病毒治疗保留率低,优先晚启动抗逆转录病毒治疗的策略比早启动抗逆转录病毒治疗的策略导致的艾滋病毒发病率更低。基于接受抗逆转录病毒治疗人数的净增加来维持固定的TPR值,可实现更大程度的艾滋病毒发病率降低,且需要快速扩大抗逆转录病毒治疗规模。

结论

我们的分析表明,如果没有关于抗逆转录病毒治疗覆盖率和保留率的信息,TPR并非抗逆转录病毒治疗项目影响的充分指标。实现早期启动并坚持治疗以提高抗逆转录病毒治疗覆盖率可能与达到特定的TPR目标同样重要。不同环境下TPR的比较应考虑疫情状况的差异。

相似文献

1
Assessing the utility of the tipping point ratio to monitor HIV treatment programmes in the era of universal access to ART.评估临界点比率在普及抗逆转录病毒治疗时代监测艾滋病治疗项目的效用。
Infect Dis Model. 2018 Mar 14;3:85-96. doi: 10.1016/j.idm.2018.03.005. eCollection 2018.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.艾滋病毒治疗即预防:对南非抗逆转录病毒疗法对艾滋病毒发病率潜在影响的数学模型的系统比较。
PLoS Med. 2012;9(7):e1001245. doi: 10.1371/journal.pmed.1001245. Epub 2012 Jul 10.
4
The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.90-90-90 策略对斯威士兰艾滋病毒 1 发病率和死亡率的影响:一项数学建模研究。
Lancet HIV. 2020 May;7(5):e348-e358. doi: 10.1016/S2352-3018(19)30436-9. Epub 2020 Feb 13.
5
Human resources for treating HIV/AIDS: needs, capacities, and gaps.治疗艾滋病毒/艾滋病的人力资源:需求、能力与差距。
AIDS Patient Care STDS. 2007 Nov;21(11):799-812. doi: 10.1089/apc.2007.0193.
6
Interventions to improve early retention of patients in antiretroviral therapy programmes in sub-Saharan Africa: A systematic review.在撒哈拉以南非洲地区改善抗逆转录病毒疗法方案中患者早期保留的干预措施:系统评价。
PLoS One. 2022 Feb 9;17(2):e0263663. doi: 10.1371/journal.pone.0263663. eCollection 2022.
7
Impact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment Targets.在新的90-90-90艾滋病治疗目标背景下扩大自愿男性医学包皮环切术以预防艾滋病的影响和成本
PLoS One. 2016 Oct 26;11(10):e0155734. doi: 10.1371/journal.pone.0155734. eCollection 2016.
8
Tuberculosis结核病
9
Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.迈向实现 90-90-90 艾滋病毒目标:南非 2017 年全国艾滋病毒调查结果。
BMC Public Health. 2020 Sep 9;20(1):1375. doi: 10.1186/s12889-020-09457-z.
10
Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study.抗逆转录病毒疗法广泛推广背景下HIV毒力的演变:一项建模研究
Virus Evol. 2016 Oct 3;2(2):vew028. doi: 10.1093/ve/vew028. eCollection 2016 Jul.

本文引用的文献

1
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling study.南非艾滋病毒疫苗接种运动的预期效果和附加值:建模研究。
Sci Rep. 2018 Apr 17;8(1):6066. doi: 10.1038/s41598-018-24268-4.
2
New insights into HIV epidemic in South Africa: key findings from the National HIV Prevalence, Incidence and Behaviour Survey, 2012.南非艾滋病毒疫情新见解:2012年全国艾滋病毒流行率、发病率及行为调查主要发现
Afr J AIDS Res. 2016;15(1):67-75. doi: 10.2989/16085906.2016.1153491.
3
Are Clade Specific HIV Vaccines a Necessity? An Analysis Based on Mathematical Models.
基于数学模型的分析:分支特异性 HIV 疫苗是否有必要?
EBioMedicine. 2015 Nov 5;2(12):2062-9. doi: 10.1016/j.ebiom.2015.11.009. eCollection 2015 Dec.
4
Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013.1990 - 2013年艾滋病死亡负担最高的30个国家的艾滋病死亡、新感染病例及抗逆转录病毒治疗覆盖率趋势
PLoS One. 2015 Jul 6;10(7):e0131353. doi: 10.1371/journal.pone.0131353. eCollection 2015.
5
Using Surveillance Data to Assess the HIV Tipping Point in the United States.利用监测数据评估美国的艾滋病毒转折点。
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e82-4. doi: 10.1097/QAI.0000000000000564.
6
Who will Benefit from a Wide-Scale Introduction of Vaginal Microbicides in Developing Countries?在发展中国家大规模引入阴道杀菌剂,谁将从中受益?
Stat Commun Infect Dis. 2010 Jan;2(1):1012. doi: 10.2202/1948-4690.1012.
7
HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model.HPTN 071(PopART):一项关于包括普遍检测和治疗在内的HIV联合预防干预措施对人群影响的整群随机试验:数学模型
PLoS One. 2014 Jan 15;9(1):e84511. doi: 10.1371/journal.pone.0084511. eCollection 2014.
8
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.暴露前预防对撒哈拉以南非洲地区HIV-1耐药性的影响有限:数学模型比较
AIDS. 2013 Nov 28;27(18):2943-51. doi: 10.1097/01.aids.0000433237.63560.20.
9
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.艾滋病毒治疗即预防:对南非抗逆转录病毒疗法对艾滋病毒发病率潜在影响的数学模型的系统比较。
PLoS Med. 2012;9(7):e1001245. doi: 10.1371/journal.pmed.1001245. Epub 2012 Jul 10.
10
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.在南非,艾滋病毒 1 型血清不一致的异性恋夫妇中预防使用抗逆转录病毒药物的最佳方法:建模研究。
PLoS Med. 2011 Nov;8(11):e1001123. doi: 10.1371/journal.pmed.1001123. Epub 2011 Nov 15.